2000
DOI: 10.1159/000020297
|View full text |Cite
|
Sign up to set email alerts
|

ESWL in Hemophiliac Patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2007
2007
2016
2016

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(3 citation statements)
references
References 8 publications
0
3
0
Order By: Relevance
“…Czaplicki and colleagues reported the outcomes of 11 patients with hemophilia who were treated by SWL for urolithiasis. 6 With the substitution of deficient coagulation factors on the day of treatment and after a total of 25 (1–6/patient) SWL sessions, nine patients (81.8%) discharged stones without any hemorrhagic complications. In a systematic review, including 25 patients, major bleeding complications were observed in 4 patients and SWL was found to be a safe method in the treatment of urinary calculi in the patients with hemophilia.…”
Section: Discussionmentioning
confidence: 96%
“…Czaplicki and colleagues reported the outcomes of 11 patients with hemophilia who were treated by SWL for urolithiasis. 6 With the substitution of deficient coagulation factors on the day of treatment and after a total of 25 (1–6/patient) SWL sessions, nine patients (81.8%) discharged stones without any hemorrhagic complications. In a systematic review, including 25 patients, major bleeding complications were observed in 4 patients and SWL was found to be a safe method in the treatment of urinary calculi in the patients with hemophilia.…”
Section: Discussionmentioning
confidence: 96%
“…45 Since this initial report, there have been a total of 13 patients with hemophilia A who have safely undergone SWL; in all of these cases, correction of clotting was through administration of factor VIII to 80% to 100% of normal values before treatment. [46][47][48][49][50] A total of four patients with hemophilia B, which is less common than hemophila A, have also been treated without complication after factor IX administration. 49,51,52 Liver failure and cirrhosis lead to reduced synthesis of clotting factors, and SWL has been safely performed when coagulopathy is corrected by administration of vitamin K or by infusion of donor plasma products, such as fresh frozen plasma.…”
Section: Coagulation and Plateletsmentioning
confidence: 99%
“…[46][47][48][49][50] A total of four patients with hemophilia B, which is less common than hemophila A, have also been treated without complication after factor IX administration. 49,51,52 Liver failure and cirrhosis lead to reduced synthesis of clotting factors, and SWL has been safely performed when coagulopathy is corrected by administration of vitamin K or by infusion of donor plasma products, such as fresh frozen plasma. 47,50,53,54 In those reports that commented on International Normalized Ratio (INR) at treatment, 1.5 was the highest at which uncomplicated SWL was performed.…”
Section: Coagulation and Plateletsmentioning
confidence: 99%